Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
- To assess potential impact of moderate and severe renal impairment on the pharmacokinetics
of cabazitaxel
Secondary Objective:
- To assess the safety of cabazitaxel in patients with various degrees of renal impairment